News

Filter

Current filters:

Cardio-vascular

201 to 210 of 96538 results

FDA Breakthrough designation for Ariad’s AP26113

FDA Breakthrough designation for Ariad’s AP26113

03-10-2014

US specialty pharma firm Ariad Pharmaceuticals says that its investigational cancer drug AP26113 has…

AP26113Ariad PharmaceuticalsOncologyPharmaceuticalRegulationResearchUSA

Strides Arcolab and Shasun Pharma to merge

Strides Arcolab and Shasun Pharma to merge

03-10-2014

The boards of Indian drugmakers Strides Arcolab and Shasun Pharmaceuticals have approved a scheme of…

GenericsIndiaMergers & AcquisitionsShasun PharmaceuticalsStrides Arcolab

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

Salix terminates merger with Cosmo, now allegedly seeking deal with Actavis

03-10-2014

Gastrointestinal specialist Salix Pharmaceuticals is reportedly seeking a deal with Ireland-headquartered…

ActavisCosmo PharmaceuticalsGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalSalixUSA

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

03-10-2014

USA-based life sciences company Sigma-Aldrich has entered into an agreement to acquire US antibody company…

AnatomyBiologyBiotechnologyImmunologicalsMergers & AcquisitionsProtein methodsSigma-AldrichUSA

International Society for Pharmaceutical Engineering launches prevention plan to tackle drug shortages

International Society for Pharmaceutical Engineering launches prevention plan to tackle drug shortages

03-10-2014

The International Society for Pharmaceutical Engineering (ISPE) is to release its Drug Shortages Prevention…

GlobalISPEISPE Drug Shortages Task TeamPharmaceuticalRegulation

EMA adopts landmark policy to take effect January 2015

EMA adopts landmark policy to take effect January 2015

03-10-2014

In a bid toward greater transparency, the European Medicines Agency has decided to publish the clinical…

EMAEuropePharmaceuticalRegulationResearch

Data uncertainties mean NICE does not recommend Roche leukemia drug

Data uncertainties mean NICE does not recommend Roche leukemia drug

03-10-2014

In yet another rejection of the company’s cancer drugs, the UK drugs watchdog, the National Institute…

GazyvaroOncologyPharmaceuticalPricingRegulationRocheUK

Mast Therapeutics names Edwin Parsley as CMO

Mast Therapeutics names Edwin Parsley as CMO

02-10-2014

US-based clinical biopharmaceutical company Mast Therapeutics has named Edwin Parsley, has joined the…

BoardroomMast TherapeuticsPharmaceuticalUSA

New approach to global markets identifies six country archetypes

New approach to global markets identifies six country archetypes

02-10-2014

Similarities in pricing and reimbursement (P&R) decision criteria and payer requirements in key pharmaceutical…

GlobalMarkets & MarketingPharmaceuticalPharmaceutical industryRegulation

201 to 210 of 96538 results

Parexel

Parexel

Back to top